Circulating miR-30a-5p and miR-182-5p in Prediabetes and Screen-Detected Diabetes Mellitus

被引:34
|
作者
Weale, Cecil Jack [1 ]
Matshazi, Don M. [1 ]
Davids, Saarah F. G. [1 ]
Raghubeer, Shanel [1 ]
Erasmus, Rajiv T. [2 ,3 ]
Kengne, Andre Pascal [4 ,5 ]
Davison, Glenda Mary [1 ]
Matsha, Tandi E. [1 ]
机构
[1] Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Dept Biomed Sci, SAMRC CPUT Cardiometab Hlth Res Unit, Cape Town, South Africa
[2] Natl Hlth Lab Serv NHLS, Fac Hlth Sci, Div Chem Pathol, Cape Town, South Africa
[3] Univ Stellenbosch, Cape Town, South Africa
[4] South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa
[5] Univ Cape Town, Dept Med, Cape Town, South Africa
来源
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY | 2020年 / 13卷
基金
英国医学研究理事会; 新加坡国家研究基金会;
关键词
Africa; miR-30a-5p; miR-182-5p; diabetes; prediabetes; DIAGNOSIS; GLUCOTOXICITY; BIOMARKERS; EXPRESSION; MICRORNAS;
D O I
10.2147/DMSO.S286081
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: microRNAs (miRNAs) have been touted as potential diagnostic and prognostic biomarkers for various diseases. The aim of the present study was to evaluate the diagnostic value of miR-30a-5p and miR-182-5p for prediabetes and screen-detected type 2 diabetes mellitus (T2DM). Methods: The study included 1270 participants (207 prediabetes, 94 screen-detected diabetes and 969 normotolerant) from the Vascular and Metabolic Health (VMH) study. Whole blood levels of miR-30a-5p and miR-182-5p were quantitated by RT-qPCR. Multivariable logistic regressions were used to relate miRNAs with prediabetes or T2DM and receiver operating characteristic (ROC) curves were used to evaluate the ability of each miRNA to diagnose these conditions. Results: Both miRNAs were significantly highly expressed in individuals with prediabetes or T2DM (both >= 3.2-fold, and p<0.001). We also observed significant under-expression in T2DM relative to prediabetes for miR-182-5p (0.49-fold, p=0.001). Age, sex and BMI-adjusted partial correlation coefficient analysis revealed a significant correlation between the two miRNAs across glucose tolerance statuses (r >= 0.932, p<0.001). In normotolerant individuals, both miRNAs showed a negative correlation with waist circumference and positive correlation with HDL-cholesterol whilst in T2DM they correlated positively with hip circumference, 2-hour insulin, HDL- and LDL-cholesterol. Multivariable logistic regressions revealed both miRNAs to be consistently and continuously associated with prediabetes or T2DM (OR>1.18, 95% 95% CI: 1.10-1.28, p<0.001), while only miR-182-5p associated with a reduced prevalence of T2DM relative to prediabetes (OR: 0.89, 95% CI: 0.83-0.96, p=0.003). In ROC analyses, miR-182-5p almost outperformed HbA1c in diagnosing prediabetes; area under the curve 0.74 vs 0.69. Conclusion: Our findings demonstrate that miR-30a-5p and miR-182-5p are associated with dysglycaemia and could potentially predict prediabetes, particularly miR-182-5p.
引用
收藏
页码:5037 / 5047
页数:11
相关论文
共 50 条
  • [1] Down regulation of miR-30a-5p and miR-182-5p in gastric cancer: Clinical impact and survival analysis
    Soliman, Shimaa E.
    Elabd, Naglaa S.
    EL-Kousy, Salah M.
    Awad, Mohamed F.
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2021, 27
  • [2] Circulating miR-182-5p and miR-5187-5p as biomarkers for the diagnosis of unprotected left main coronary artery disease
    Zhu, Lingping
    Chen, Tong
    Ye, Wenrui
    Wang, Jun-Yao
    Zhou, Ji-Peng
    Li, Zhen-Yu
    Li, Chuan-Chang
    JOURNAL OF THORACIC DISEASE, 2019, 11 (05) : 1799 - 1808
  • [3] Effect of miR-182-5p on apoptosis in myocardial infarction
    Niu, Nan
    Miao, Huangtai
    Ren, Hongmei
    HELIYON, 2023, 9 (11)
  • [4] The Role of miR-182-5p in Hepatocarcinogenesis of Trichloroethylene in Mice
    Jiang, Yan
    Chen, Jiahong
    Yue, Cong
    Zhang, Hang
    Tong, Jian
    Li, Jianxiang
    Chen, Tao
    TOXICOLOGICAL SCIENCES, 2017, 156 (01) : 208 - 216
  • [5] miR-182-5p and miR-183-5p Act as GDNF Mimics in Dopaminergic Midbrain Neurons
    Roser, Anna-Elisa
    Gomes, Lucas Caldi
    Halder, Rashi
    Jain, Gaurav
    Maass, Fabian
    Toenges, Lars
    Tatenhorst, Lars
    Baehr, Mathias
    Fischer, Andre
    Lingor, Paul
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2018, 11 : 9 - 22
  • [6] Assessment of miR-19b-3p, miR-182-5p, and miR-155-5p expression and its relation
    Abdelneam, Ahmed Ibrahim
    Al-Dhubaibi, Mohammed Saleh
    Bahaj, Saleh Salem
    Mohammed, Ghada Farouk
    Atef, Lina Mohammed
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [7] Clinical Significance of miR-183-3p and miR-182-5p in NSCLC and Their Correlation
    Zhang, Tianxiang
    Li, Wei
    Gu, Meng
    Wang, Ziyu
    Zhou, Shijie
    Hao, Xuefeng
    Li, Weiying
    Xu, Shaofa
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 3539 - 3550
  • [8] Two oncomiRs, miR-182-5p and miR-103a-3p, Involved in Intravenous Leiomyomatosis
    Barnas, Edyta
    Skret-Magierlo, Joanna Ewa
    Paszek, Sylwia
    Kaznowska, Ewa
    Potocka, Natalia
    Skret, Andrzej
    Sakowicz, Agata
    Zawlik, Izabela
    GENES, 2023, 14 (03)
  • [9] Expression of miR-30a-5p in Expression of Mir-30A-5P in Extracellular Vesicle as a Prognostic Biomarker for Non Small Cell Lung Cancer Therapy
    Pangaribuan, M. T. G.
    Zaini, J.
    Sutandyo, N.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S504 - S504
  • [10] Emerging biologic and clinical implications of miR-182-5p in gynecologic cancers
    Zehtabi, Mojtaba
    Ghaedrahmati, Farhoodeh
    Dari, Mahrokh Abouali Gale
    Moramezi, Farideh
    Kempisty, Bartosz
    Mozdziak, Paul
    Farzaneh, Maryam
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,